Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

The Impact of Physical Exercise on Working Memory in Elderly People With Mild Cognitive Impairment

11 giugno 2026 aggiornato da: Peng Wang, Shanghai University of Sport

Age-related cognitive decline has evolved into a global public health concern, with deteriorated executive function serving as its predominant manifestation. Working memory, a vital component of executive function, refers to a capacity-limited system that temporarily stores and manipulates information during sophisticated cognitive processes such as language comprehension, learning, and reasoning. It constitutes the core of general cognitive functioning and underpins daily functional performance.

The prefrontal cortex is a pivotal brain region subserving working memory and is highly vulnerable to pathological aging. Advancing age triggers prefrontal cortical atrophy and reduced synaptic density, which in turn induces working memory impairment. Consistently, existing evidence identifies working memory as one of the cognitive domains most susceptible to aging and among the first functions compromised in neurodegenerative disorders including Alzheimer's disease.

As a non-pharmacological strategy, physical exercise intervention has been validated to exert favorable effects on cognitive improvement. Both aerobic and resistance training effectively ameliorate working memory; nevertheless, head-to-head evidence comparing their intervention efficacy among older adults with mild cognitive impairment (MCI) remains scarce, particularly regarding underlying neurophysiological mechanisms. This study aims to explore the impacts of physical training on working memory in older women living with MCI.

Accordingly, the present study aimed to investigate the effects of both a single exercise session and a 12-week intervention on upper- and lower-limb muscle strength and working memory in older women with MCI. In addition, we sought to examine the statistical associations between changes in muscle strength and working memory, with particular attention to the potential mediating role of muscle strength changes. Previous studies have suggested that interventions targeting muscle strength and physical function in middle-aged and older adults are commonly implemented over 12-52 weeks at a frequency of two to three sessions per week, whereas exercise interventions targeting cognitive function in older adults are often conducted over 12-24 weeks at a similar frequency. Based on this evidence, together with feasibility considerations in residential care settings, we adopted a 12-week intervention delivered three times per week. This study contributes to the literature by integrating both acute and chronic effects within a single randomized controlled framework and by exploring the muscle strength-cognition pathway as a potential explanatory mechanism for exercise-related cognitive benefits.

Panoramica dello studio

Tipo di studio

Interventistico

Iscrizione (Stimato)

80

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Cina, 200438
        • Shanghai University of Sport

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto più anziano

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  1. Age >= 65years;
  2. Free from major organic diseases or cardiovascular diseases, and showing no contraindications to exercise according to the pre-exercise screening questionnaire developed by the American Heart Association (AHA) and the American College of Sports Medicine (ACSM);
  3. Able to communicate effectively and, subject to their condition, cooperate in completing questionnaires and tests;
  4. Willing to participate in this study and sign an informed consent form.

Exclusion Criteria:

  1. Suffering from severe cognitive impairment, mental illness or other neurodegenerative diseases (such as Parkinson's dementia, stroke, frontotemporal degeneration, vascular dementia, Lewy body dementia, etc.), where the condition impairs communication or the ability to follow experimental instructions;
  2. Suffering from severe physical injuries that prevent prolonged standing, standing or participation in physical activities;
  3. Currently taking, or having taken in the recent past, psychotropic drugs or medications that affect physical mobility;
  4. Plans for surgical treatment in the near future (within the next 6 months);
  5. Unwillingness to participate in or withdrawal from this study.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Terapia di supporto
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Resistance band exercise intervention
Perform resistance training using Thera-Band resistance bands. Warm up for 5 minutes; proceed to the main workout, which consists of 10 exercises. Perform 2 sets of each exercise, with 8 to 12 repetitions per set, resting for 1 minute between sets. The session lasts approximately 25 to 30 minutes; finish with a cool-down and stretching.
Perform resistance training using Thera-Band resistance bands. Warm up for 5 minutes; proceed to the main workout, which consists of 10 exercises. Perform 2 sets of each exercise, with 8 to 12 repetitions per set, resting for 1 minute between sets. The session lasts approximately 25 to 30 minutes; finish with a cool-down and stretching.
Sperimentale: Brisk walking intervention
Warm up for 5 minutes, then walk briskly for 25 to 30 minutes once you reach your target heart rate for moderate intensity (65%-75% of HRmax); finish with a cool-down.
Warm up for 5 minutes, then walk briskly for 25 to 30 minutes once you reach your target heart rate for moderate intensity (65%-75% of HRmax); finish with a cool-down.
Sperimentale: Eight-Section brocade exercise intervention
A 5-minute warm-up and stretching session; followed by two sets of the 'Eight Brocades' fitness qigong routine compiled by the General Administration of Sport, lasting approximately 24 minutes in total; and finally, a cool-down and relaxation session.
A 5-minute warm-up and stretching session; followed by two sets of the 'Eight Brocades' fitness qigong routine compiled by the General Administration of Sport, lasting approximately 24 minutes in total; and finally, a cool-down and relaxation session.
Comparatore placebo: Control group
Maintain current routine.
Maintain current routine.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
The N-back working memory task
Lasso di tempo: This study runs from 4 March 2026 to 31 August 2026. Each participant receives assessments within one week at baseline and one week after intervention.
Implemented using E-Prime 3.0 software, with Arabic numerals as stimuli. Participants were required to respond according to the task instructions, recording reaction time (RT)and accuracy (ACC).
This study runs from 4 March 2026 to 31 August 2026. Each participant receives assessments within one week at baseline and one week after intervention.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Montreal Cognitive Assessment Scale
Lasso di tempo: This study runs from 4 March 2026 to 31 August 2026. Each participant receives assessments within one week at baseline and one week after intervention.
Global cognitive function was assessed using the Montreal Cognitive Assessment (MoCA), which includes 11 items covering attention, executive function, memory, language, visuospatial ability, abstraction, calculation, and orientation. The total score ranges from 0 to 30, with higher scores indicating better cognitive function. One point was added for participants with fewer than 12 years of education.
This study runs from 4 March 2026 to 31 August 2026. Each participant receives assessments within one week at baseline and one week after intervention.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Direttore dello studio: Xing Wang, Shanghai University of Sport

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

4 marzo 2026

Completamento primario (Stimato)

31 agosto 2026

Completamento dello studio (Stimato)

31 agosto 2026

Date di iscrizione allo studio

Primo inviato

7 giugno 2026

Primo inviato che soddisfa i criteri di controllo qualità

11 giugno 2026

Primo Inserito (Effettivo)

12 giugno 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

12 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

11 giugno 2026

Ultimo verificato

1 giugno 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 102772025RT275 (Identificatore di registro: Physical Exercise on Working Memory in Old People with MCI)
  • 22BTY076 (Altro numero di sovvenzione/finanziamento: National Social Science Fund of China)
  • 11DZ2261100 (Altro numero di sovvenzione/finanziamento: Shanghai Science and Technology Commission)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi